MediLumine’s Mvivo Au contrast agent was injected at a dose of 0.1 ml in nude mice grafted with Sdhb(-/-) and scanned with Mediso nanoScan PET/CT at Inserm U970, Paris, France (Viel T, Yoganathan T, Perez-Liva M, Tavitian B). 3D CT images of tumor vasculature were generated with Amira 3D visualization and analysis software for life sciences (Thermo Fisher Scientific).
Medilumine is pleased to announce a new distribution partnership with NanoPET Pharma through its Viscover brand. Medilumine is now an authorized distributor of the full
Recent preclinical research by the laboratory of Dr. Hisataka Kobayashi (Director of Molecular Theranostics, NIH) explored the potential of carbonic anhydrase‑9 (CA9) as a theranostic
